<DOC>
	<DOCNO>NCT02133456</DOCNO>
	<brief_summary>To monitor safety Shanghai Institute Biological Products Company 's influenza vaccine subject age 3 year old Adverse Events Following Immunization Surveillance System China . The hypothesis significant difference occurrence adverse event among influenza vaccine manufacture SIBP company .</brief_summary>
	<brief_title>A Post-marketing Safety Study Inactivated , Split-virion Influenza Vaccine Subjects Aged 3 Years Older</brief_title>
	<detailed_description>Inactivated split-virion vaccine Shanghai Institute Biological Products Company use 10 year Beijing population . Some 160 thousand dos sell subject age 3 year old area . We review summarize spontaneously reported adverse event safety surveillance . Adverse event collect Adverse Events Following Immunization ( AEFI ) Surveillance System . Beijing CDC local prefectural CDC must organize expert panel investigate adverse event assess causality , use criterion base Chinese Standard Procedures Vaccination . The panel consist physician , epidemiologist , pharmacist , relevant expert . In general , expert panel investigate death , life-threatening illness , permanent disability , immunization-program manager vaccination provider investigate common , minor adverse event . Adverse event classify one five category : vaccine reaction ( common minor rare serious ) , program error , coincidental illness , psychogenic reaction , unclassifiable event . At time vaccination , vaccinee instruct report adverse event physician vaccination provider . The following adverse event require report : adverse event fatal result disability cluster event ( i.e. , notably high number similar adverse event related certain vaccine ) ; anaphylaxis allergic reaction occur within 24 hour vaccination ; fever ( axillary temperature , &gt; 37.5°C ) , angioedema , local injection-site reaction ( diameter , &gt; 2.5 cm ) occur within 5 day vaccination ; purpura , Arthus reaction , febrile convulsion , seizure , polyneuritis occur within 15 day vaccination ; Guillain-Barré syndrome occur within 3 month vaccination . Other reaction common minor ( e.g. , mild pain fatigue ) require report .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Males female age 3 year day immunization , eligible seasonal influenza vaccination . Recipients SIBP 's inactivated , splitvirion influenza vaccine . History serious reaction flu vaccine , material vaccine , egg ( include ovalbumin ) chicken protein . Receipt live vaccine within 4 week prior Study Day 1 . Any condition , opinion study doctor , might interfere evaluation study objective .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>safety</keyword>
	<keyword>influenza vaccine</keyword>
	<keyword>post-marketing</keyword>
</DOC>